Armin Kern
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Microbial Natural Products and Biosynthesis
Papers in
-
- Chemical Synthesis and Analysis 3
- Oncology 3
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- Martin Radtke (4 shared papers)M. Kugler (1 shared paper)G�nther Jung (1 shared paper)Claudius Rapp (1 shared paper)W. Loeffler (1 shared paper)Wolfgang Karl (2 shared papers)Rolf Angerbauer (2 shared papers)Michael Gerisch (4 shared papers)
In The Last Decade
Armin Kern
11 papers receiving 430 citations
Peers
Comparison fields: 5 of 78
- Pharmacology 73
- Pharmacology 58
- Biochemistry 22
- Toxicology 10
- Cardiology and Cardiovascular Medicine 57
Countries citing papers authored by Armin Kern
This map shows the geographic impact of Armin Kern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armin Kern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armin Kern more than expected).
Fields of papers citing papers by Armin Kern
This network shows the impact of papers produced by Armin Kern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armin Kern. The network helps show where Armin Kern may publish in the future.
Co-authors
The 25 scholars most cited alongside Armin Kern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 148 | |
| 2 | 1990 | 96 | |
| 3 | Metabolism of cerivastatin by human liver microsomes in vitro. Characterization of primary metabolic pathways and of cytochrome P450 isozymes involved. | 1997 | 69 |
| 4 | Biotransformation of cerivastatin in mice, rats, and dogs in vivo. | 1998 | 44 |
| 5 | 1999 | 39 | |
| 6 | 1985 | 20 | |
| 7 | 1985 | 19 | |
| 8 | 2020 | 9 | |
| 9 | 1989 | 8 | |
| 10 | 2022 | 4 | |
| 11 | 2009 | 2 |
About Armin Kern
Armin Kern is a scholar working on Molecular Biology, Oncology, Pharmacology, Organic Chemistry and Pulmonary and Respiratory Medicine, having authored 11 papers that have together received 458 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Chemical Synthesis and Analysis (3 papers), Nitric Oxide and Endothelin Effects (2 papers), Antimicrobial Peptides and Activities (2 papers), Biotin and Related Studies (2 papers), Pulmonary Hypertension Research and Treatments (2 papers) and Click Chemistry and Applications (1 paper). The work is most often cited by research in Pharmacology (73 citations), Pharmacology (58 citations), Biochemistry (22 citations), Toxicology (10 citations) and Cardiology and Cardiovascular Medicine (57 citations). Armin Kern has collaborated with scholars based in Germany, Italy and Japan. Frequent co-authors include Martin Radtke, M. Kugler, G�nther Jung, Claudius Rapp, W. Loeffler, Wolfgang Karl, Rolf Angerbauer, Michael Gerisch, Elke Stahl and Joachim Mittendorf. Their work appears in journals such as Alternatives to Laboratory Animals, ChemMedChem, The Journal of Antibiotics, Xenobiotica and Archives of Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.